The U.S. Food and Drug Administration just rejected an application that would have authorized the use of a promising psychedelic compound, MDMA, for the treatment of post-traumatic stress disorder, a condition affecting 13 million Americans, In its denial, the FDA suggested the company, Lykos Therapeutics, instead conduct another large study — a proposal that could take years. Fortunately, states need not wait for the sluggish federal bureaucracy to act. Some have already established promising regulations to give veterans, sexual assault survivors and others suffering from PTSD safe and effective access to psychedelic-assisted therapies. Psychedelic research has been stymied sinc
Hence then, the article about psychedelics are a mental health miracle so why is the fda holding back was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Psychedelics are a mental health miracle — so why is the FDA holding back? )